Multikinase inhibitors to treat hepatocellular carcinoma failures to sorafenib-time has come for a better approach
Ann Transl Med
.
2020 Oct;8(19):1255.
doi: 10.21037/atm-2020-79.
Authors
Saleh A Alqahtani
1
2
,
Massimo Colombo
3
Affiliations
1
Liver Transplant Unit, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
2
Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, MD, USA.
3
Center of Translational Research in Hepatology, Humanitas Hospital, Rozzano, Italy.
PMID:
33178787
PMCID:
PMC7607112
DOI:
10.21037/atm-2020-79
No abstract available
Publication types
Editorial
Comment